Key facts
- Epiminder (ASX: EPI)’s last known valuation is $171.0M (Dec 2025).
- It has raised $126.2M; the latest was IPO ($81.3M) in Dec 2025.
- Status: Publicly Held.
- ·Watchlist + deal alerts for Epiminder (ASX: EPI)
- ·The full record, as it builds
Funding rounds
No funding rounds for Epiminder (ASX: EPI) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Epiminder (ASX: EPI)
Epiminder Ltd is a medical device and information solutions company focused on developing diagnostic and treatment tools for epilepsy. Its system is a sub-scalp device for continuous monitoring of electrographic brain activity and a set of information solutions, providing patients and their healthcare professionals with detailed data over an extended period.
- Sector
- Healthcare
- HQ
- Melbourne, Australia
- Founded
- 2017
- Employees
- 27
- Website
- epiminder.com/
- Ownership
- Publicly Held
Epiminder (ASX: EPI) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Epiminder (ASX: EPI) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Epiminder (ASX: EPI) in its N-PORT filings yet. We sweep new filings monthly.